Biotech ripe for 'cascade of dealmaking' - Here are the top companies to watch By Investing.com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
Analysts’ Latest Move Suggests Tilray’s a Buy Under $20 TLRY stock might not revisit $60 any time soon. However, under $20, it s a good long-term buy June 9, 2021 By Will Ashworth, InvestorPlace Contributor Jun 9, 2021, 11:42 am EDT June 9, 2021
Tilray (NASDAQ:
TLRY) from neutral to overweight. However, at the same time, Zuanic lowered his price target on TLRY stock to $22, down from $30.25.
Source: Jetacom Autofocus / Shutterstock.com
I must admit I’ve never been able to understand analyst decisions about stocks they cover.
If a stock’s target price is lowered by $8.25, as is the case with Tilray, how is it suddenly a buy? Alternatively, if you raise its rating from neutral to overweight, how is an $8.25 cut to its target price justified?